{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:58:32Z","timestamp":1790618312301,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"University of Antwerp (Lanceringsproject)","award":["5198"],"award-info":[{"award-number":["5198"]}]},{"name":"Fund for Scientific Research, Flanders (FWO, Belgium)","award":["6241"],"award-info":[{"award-number":["6241"]}]},{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"crossref","award":["2013T093 BAV"],"award-info":[{"award-number":["2013T093 BAV"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"crossref","award":["5446"],"award-info":[{"award-number":["5446"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ejmg.2015.10.010","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T19:32:36Z","timestamp":1445887956000},"page":"695-703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["TGF-\u03b2 signalopathies as a paradigm for translational medicine"],"prefix":"10.1016","volume":"58","author":[{"given":"Elyssa","family":"Cannaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerarda","family":"van de Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Verstraeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lut","family":"Van Laer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Loeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmg.2015.10.010_bib1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ajmg.a.31202","article-title":"FBN1, TGFBR1, and the Marfan-craniosynostosis\/mental retardation disorders revisited","author":"Ades","year":"2006","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.ejmg.2015.10.010_bib2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.2366","article-title":"The paradoxical TGF-beta vasculopathies","author":"Akhurst","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ajmg.a.36340","article-title":"De novo exon 1 missense mutations of SKI and Shprintzen-Goldberg syndrome: two new cases and a clinical review","author":"Au","year":"2014","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.ejmg.2015.10.010_bib4","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/hmg\/ddv037","article-title":"The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele","author":"Aubart","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajmg.1320290316","article-title":"International nosology of heritable disorders of connective tissue, Berlin, 1986","author":"Beighton","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/hrt.2010.210286","article-title":"Surgical management of aortic root disease in Marfan syndrome: a systematic review and meta-analysis","author":"Benedetto","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.ejmg.2015.10.010_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/thx.23.4.338","article-title":"A\u00a0technique for complete replacement of the ascending aorta","author":"Bentall","year":"1968","journal-title":"Thorax"},{"key":"10.1016\/j.ejmg.2015.10.010_bib8","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1101\/gad.11.16.2029","article-title":"Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development","author":"Berk","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmg.2015.10.010_bib9","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2015.01.040","article-title":"Mutations in a TGF-beta ligand, TGFB3, cause syndromic aortic aneurysms and dissections","author":"Bertoli-Avella","year":"2015","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/1358863X15569868","article-title":"Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome","author":"Bhatt","year":"2015","journal-title":"Vasc. Med."},{"key":"10.1016\/j.ejmg.2015.10.010_bib11","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/ajmg.a.32229","article-title":"Severe Marfan syndrome due to FBN1 exon deletions","author":"Blyth","year":"2008","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.ejmg.2015.10.010_bib12","series-title":"TGFB2 Mutations Cause Familial Thoracic Aortic Aneurysms and Dissections Associated with Mild Systemic Features of Marfan Syndrome Nature Genetics","first-page":"916","author":"Boileau","year":"2012"},{"key":"10.1016\/j.ejmg.2015.10.010_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yjmcc.2005.11.009","article-title":"A\u00a0fibrillin-1-fragment containing the elastin-binding-protein GxxPG consensus sequence upregulates matrix metalloproteinase-1: biochemical and computational analysis","author":"Booms","year":"2006","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib14","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","author":"Brooke","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmg.2015.10.010_bib15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ajhg.2012.10.002","article-title":"In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome","author":"Carmignac","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.200608167","article-title":"Fibrillin-1 regulates the bioavailability of TGFbeta1","author":"Chaudhry","year":"2007","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to beta-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study","author":"Chiu","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejmg.2015.10.010_bib18","first-page":"e73","article-title":"Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9","author":"Chung","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmg.2015.10.010_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(89)90291-2","article-title":"The ski oncogene induces muscle differentiation in quail embryo cells","author":"Colmenares","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.ejmg.2015.10.010_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","article-title":"Revised\u00a0diagnostic criteria for the Marfan syndrome","author":"De Paepe","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/cr.2008.324","article-title":"Ski and SnoN, potent negative regulators of TGF-beta signaling","author":"Deheuninck","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmg.2015.10.010_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ejmg.2015.10.010_bib23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/ng.2421","article-title":"Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm","author":"Doyle","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08648","article-title":"A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome","volume":"4","author":"Doyle","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.ejmg.2015.10.010_bib25","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0003-4975(97)00061-1","article-title":"Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan's syndrome","author":"Fleischer","year":"1997","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ejmg.2015.10.010_bib26","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.ijcard.2013.03.033","article-title":"Circulating transforming growth factor-beta as a prognostic biomarker in Marfan syndrome","author":"Franken","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome","author":"Franken","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib28","first-page":"10","article-title":"Diagnosis and genetics of Marfan syndrome","author":"Franken","year":"2014","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ejmg.2015.10.010_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2350-12-119","article-title":"Characterization of large genomic deletions in the FBN1 gene using multiplex ligation-dependent probe amplification","author":"Furtado","year":"2011","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI69666","article-title":"Angiotensin II-dependent TGF-beta signaling contributes to Loeys-Dietz syndrome vascular pathogenesis","author":"Gallo","year":"2014","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ejmg.2015.10.010_bib31","first-page":"e101","article-title":"The effect of beta-blocker therapy on progressive aortic dilatation in children and adolescents with Marfan's syndrome: a meta-analysis","author":"Gao","year":"2011","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ejmg.2015.10.010_bib32","first-page":"S189","article-title":"Modulation of transforming growth factor-beta signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers","author":"Geirsson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejmg.2015.10.010_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2005.11.116","article-title":"The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis","author":"Gersony","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCRESAHA.113.300675","article-title":"Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-beta signaling and vascular smooth muscle cell contractility","author":"Gillis","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmg.2015.10.010_bib35","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJM199904293401702","article-title":"Replacement of the aortic root in patients with Marfan's syndrome","author":"Gott","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmg.2015.10.010_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng.780","article-title":"Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1","author":"Goudie","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib37","first-page":"320","article-title":"Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers","author":"Grady","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmg.2015.10.010_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/dds439","article-title":"Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice","author":"Guo","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4331\/wjbc.v3.i3.41","article-title":"Transforming growth factor-beta and smooth muscle differentiation","author":"Guo","year":"2012","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.ejmg.2015.10.010_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model\u00a0of Marfan syndrome","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejmg.2015.10.010_bib41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0002-8703(97)70248-5","article-title":"Heterogeneous aortic response to acute beta-adrenergic blockade in Marfan syndrome","author":"Haouzi","year":"1997","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejmg.2015.10.010_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ejhg.2010.174","article-title":"The clinical spectrum of complete FBN1 allele deletions","author":"Hilhorst-Hofstee","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1399-0004.2012.01931.x","article-title":"An unanticipated copy number variant of chromosome 15 disrupting SMAD3 reveals a three-generation family at serious risk for aortic dissection","author":"Hilhorst-Hofstee","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib44","first-page":"e266","author":"Hiratzka","year":"2010"},{"key":"10.1016\/j.ejmg.2015.10.010_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1192149","article-title":"Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice","author":"Holm","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmg.2015.10.010_bib46","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1074\/jbc.M209256200","article-title":"Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein","author":"Isogai","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmg.2015.10.010_bib47","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome","author":"Judge","year":"2004","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ejmg.2015.10.010_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ajmg.a.31006","article-title":"Molecular pathology of Shprintzen-Goldberg syndrome","author":"Kosaki","year":"2006","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.ejmg.2015.10.010_bib49","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan's syndrome","author":"Lacro","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmg.2015.10.010_bib50","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjcard.2006.08.048","article-title":"Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome","author":"Ladouceur","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib51","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/BRS.0b013e3181a3c7c7","article-title":"A\u00a0continuous observation of the degenerative process in the intervertebral disc of Smad3 gene knock-out mice","author":"Li","year":"2009","journal-title":"Spine Phila Pa 1976"},{"key":"10.1016\/j.ejmg.2015.10.010_bib52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nature10145","article-title":"Lessons on the pathogenesis of aneurysm from heritable conditions","author":"Lindsay","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmg.2015.10.010_bib53","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/ng.2349","article-title":"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm","author":"Lindsay","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1034\/j.1399-0004.2001.590311.x","article-title":"The use of intragenic polymorphisms in determination of the genomic relevance of whole-exon deletions in MLH1 and MSH2","author":"Liu","year":"2001","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib55","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/hmg\/5.10.1581","article-title":"Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome","author":"Liu","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1511","article-title":"A\u00a0syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2","author":"Loeys","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","author":"Loeys","year":"2010","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib58","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor","author":"Loeys","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmg.2015.10.010_bib59","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/aja.1002010407","article-title":"Protooncogene c-ski is expressed in both proliferating and postmitotic neuronal populations","author":"Lyons","year":"1994","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.ejmg.2015.10.010_bib60","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/gim.2014.11","article-title":"Loeys-Dietz syndrome: a primer for diagnosis and management","author":"MacCarrick","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejmg.2015.10.010_bib61","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/PAS.0b013e31817f3661","article-title":"Histopathologic findings in ascending aortas from individuals with Loeys-Dietz syndrome (LDS)","author":"Maleszewski","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib62","first-page":"220","article-title":"A\u00a0case of congenital malformation of the four limbs, most pronounced in the extremities, characterized by an extension of the bones with a certain degree of slimming (in French)","author":"Marfan","year":"1886","journal-title":"Bull. M\u00e9moires Soc. M\u00e9d. H\u00f4pitaux Paris"},{"key":"10.1016\/j.ejmg.2015.10.010_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00439-007-0371-x","article-title":"Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome","author":"Matyas","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib64","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/ajmg.a.36593","article-title":"De novo mutation of the latency-associated peptide domain of TGFB3 in a patient with overgrowth and Loeys-Dietz syndrome features","author":"Matyas","year":"2014","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.ejmg.2015.10.010_bib65","first-page":"S168","article-title":"Pravastatin reduces Marfan aortic dilation","author":"McLoughlin","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejmg.2015.10.010_bib66","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","article-title":"Marfan Sartan: a randomized, double-blind, placebo-controlled trial","author":"Milleron","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejmg.2015.10.010_bib67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","author":"Neptune","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib68","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI200422715","article-title":"TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome","author":"Ng","year":"2004","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ejmg.2015.10.010_bib69","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1101\/gad.13.4.412","article-title":"Ski is a component of the histone deacetylase complex required for transcriptional repression by mad and thyroid hormone receptor","author":"Nomura","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmg.2015.10.010_bib70","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCULATIONAHA.105.537340","article-title":"Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections","author":"Pannu","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejmg.2015.10.010_bib71","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.amjcard.2013.06.019","article-title":"Usefulness of losartan on the size of the ascending aorta in an unselected cohort of children, adolescents, and young adults with Marfan syndrome","author":"Pees","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib72","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng1097-218","article-title":"Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome","author":"Pereira","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib73","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","article-title":"Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1","author":"Pereira","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmg.2015.10.010_bib74","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ahj.2015.01.011","article-title":"Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: a report from the Marfan treatment Trialists' Collaboration","author":"Pitcher","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejmg.2015.10.010_bib75","doi-asserted-by":"crossref","first-page":"26249","DOI":"10.1074\/jbc.M304459200","article-title":"The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation","author":"Prunier","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmg.2015.10.010_bib76","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.med.51.1.481","article-title":"The Marfan syndrome","author":"Pyeritz","year":"2000","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejmg.2015.10.010_bib77","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCRESAHA.111.248161","article-title":"Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms","author":"Regalado","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmg.2015.10.010_bib78","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ijcard.2012.09.029","article-title":"Thoracic aortic-aneurysm and dissection in association with significant mitral valve disease caused by mutations in TGFB2","author":"Renard","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib79","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/ajmg.a.36056","article-title":"A\u00a0mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with Marfan and Loeys-Dietz syndrome","author":"Rienhoff","year":"2013","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.ejmg.2015.10.010_bib80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12881-014-0091-8","article-title":"Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation","author":"Ritelli","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib81","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0741-5214(96)70153-2","article-title":"Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms","author":"Sakalihasan","year":"1996","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.ejmg.2015.10.010_bib82","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0002-9149(94)90762-5","article-title":"Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome","author":"Salim","year":"1994","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib102","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ejhg.2014.61","article-title":"The SMAD-binding domain of SKI: a hotspot for de novo mutations causing Shprintzen-Goldberg syndrome","author":"Schepers","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib83","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/302582","article-title":"Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes","author":"Schrijver","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib84","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s004390050414","article-title":"The pathogenicity of the Pro1148Ala substitution in the FBN1 gene: causing or predisposing to Marfan syndrome and aortic aneurysm, or clinically innocent?","author":"Schrijver","year":"1997","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib85","first-page":"1301","article-title":"Prevention of coronary heart disease with\u00a0pravastatin in men with hypercholesterolemia","author":"Shepherd","year":"1995","journal-title":"West Scotl. Coron. Prev. Study Group N. Engl. J. Med."},{"key":"10.1016\/j.ejmg.2015.10.010_bib86","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ejmg.2015.10.010_bib87","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome","author":"Shores","year":"1994","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmg.2015.10.010_bib88","first-page":"65","article-title":"A\u00a0recurrent pattern syndrome of craniosynostosis associated with arachnodactyly and abdominal hernias","author":"Shprintzen","year":"1982","journal-title":"J.\u00a0Craniofac Genet. Dev. Biol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib89","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0002-9149(00)80066-1","article-title":"Life expectancy in the Marfan syndrome","author":"Silverman","year":"1995","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib90","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng0296-209","article-title":"Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome","author":"Sood","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib91","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.ejhg.5200582","article-title":"Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40","author":"Tiecke","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib92","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ng.744","article-title":"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis","author":"van de Laar","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib93","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/jmedgenet-2011-100382","article-title":"Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome","author":"van de Laar","year":"2012","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ejmg.2015.10.010_bib94","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/HCO.0b013e32833f0220","article-title":"The Loeys-Dietz syndrome: an update for the clinician","author":"Van Hemelrijk","year":"2010","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib95","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<326::AID-HUMU10>3.0.CO;2-1","article-title":"P1148A in fibrillin-1 is not a mutation leading to Shprintzen-Goldberg syndrome","author":"Watanabe","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejmg.2015.10.010_bib96","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/j.1460-2075.1995.tb07214.x","article-title":"GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex","author":"Wieser","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmg.2015.10.010_bib97","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/hrt.2006.109454","article-title":"Medical treatment of Marfan syndrome: a time for change","author":"Williams","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.ejmg.2015.10.010_bib98","doi-asserted-by":"crossref","first-page":"S757","DOI":"10.1016\/j.athoracsur.2006.10.091","article-title":"Early surgical experience with Loeys-Dietz: a new syndrome of aggressive thoracic aortic aneurysm disease","author":"Williams","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ejmg.2015.10.010_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2009.10.039","article-title":"Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome","author":"Yang","year":"2010","journal-title":"J.\u00a0Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ejmg.2015.10.010_bib100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1083\/jcb.153.1.35","article-title":"TGF-beta\/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage","author":"Yang","year":"2001","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ejmg.2015.10.010_bib101","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/sj.ejhg.5201034","article-title":"Mutation analysis of the Smad3 gene in human osteoarthritis","author":"Yao","year":"2003","journal-title":"Eur. J. Hum. Genet."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721215300343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721215300343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:42:32Z","timestamp":1761709352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721215300343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":102,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1769721215300343"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2015.10.010","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TGF-\u03b2 signalopathies as a paradigm for translational medicine","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2015.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}